Rationale: Ca V 1.2 channels are essential for excitation-contraction coupling in the cardiovascular system, and alternative splicing optimizes its role. Galectin-1 (Gal-1) has been reported to regulate vascular smooth muscle cell (VSMC) function and play a role in pulmonary hypertension. We have identified Gal-1 multiple times in yeast 2-hybrid assays using the Ca V 1.2 I-II loop as bait.
T he Ca V 1.2 L-type calcium channels (LTCCs) are the primary conduits for Ca 2ϩ influx that lead to initiation of numerous physiological processes, including muscle excitation-contraction coupling, neurotransmitter release, gene expression, and hormone secretion. Under optimal conditions, Ca 2ϩ influx through the activated Ca V 1.2 channels in the vascular smooth muscle cells (VSMCs) tightly influences the contractility of small arteries and arterioles, and maintains the myogenic tone of resistance vessels. 1, 2 However, if this process goes awry during the pathogenesis of hypertension, an increase in Ca 2ϩ influx may contribute to the development of an abnormal vascular tone and result in elevated peripheral vascular resistance. 3, 4 Of the 4 subunits (␣ 1 , ␤, ␣2/␦, and ␥) that composed the calcium channels, the Ca V ␣ 1 subunit not only forms the aqueous pore but also possesses the voltage sensor, gating apparatus and sites for channel regulation by second messengers, drugs, and toxins. 5, 6 Within the intracellular linker region between homologous domains I and II of ␣ 1 subunit (I-II loop) is the ␣ 1 -subunit interaction domain (AID), a site where the auxiliary Ca V ␤ subunit binds to traffic ␣ 1 subunit to cell membrane. 7 Moreover, alternative splicing at the Ca V 1.2 I-II loop produces a subpopulation of Ca V 1.2 channel splice variant that contain exon 9*, which is important for vasotone maintenance in blood vessels ( Figure 1A ). 8 -11 To date, we and others have identified and characterized 3 predominant Ca V 1.2 splice combinations that are found in arterial smooth muscles, namely, Ca V 1.2 77WT (1-8-⌬9*-33), Ca V 1.2 SM (1-8-9*-⌬33), and Ca V 1.2 b (1-8-9*-33). 9, 10, 12 Galectins are a family of carbohydrate-binding proteins with an affinity for ␤-galactosides. 13 Galectin-1 (Gal-1) plays a number of roles in physiological and pathological situations. While extracellular Gal-1 regulates cell-cell and cellmatrix interactions, the immune response, apoptosis, and neoplastic transformation, intracellular Gal-1 regulates the cell cycle, RNA splicing, and transcription. 14, 15 It has been reported that Gal-1 is a modulator of vascular functions, including VSMC differentiation, proliferation, and migra-tion. 16, 17 Furthermore, Gal-1 has been implicated in the regulation of blood pressure, which showed that Gal-1 Ϫ/Ϫ null mice developed higher pulmonary blood pressure under acute hypoxia compared with wildtype mice. 18 In this study, we unexpectedly discovered that Gal-1 binds to the subpopulation of Ca V 1.2 channels that are devoid of alternatively spliced exon 9*. The interaction of Gal-1 with Ca V 1.2 channels clearly inhibited channel function and in resistance arteries resulted in lower constriction of the smooth muscles.
Methods

Yeast 2-Hybrid Assay
Yeast 2-hybrid screen was performed using the cytoplasmic I-II loop of human Ca V 1.2 (in a pGBKT7 vector) as bait in an X ␣-Gal in-gel assay. A total of 75 quadruple DO and 25 triple DO plates were used for the assay.
A human aorta cDNA library (Clontech #HL4040AH) was used for screening. Colonies were observed after transformation from day 5 to day 8.
GST Pull-Down Assay
GST pull-down assays were performed using glutathione sepharose 4B GST beads (GE Healthcare, Little Chalfont, UK) to isolate purified GST linked to different exons of Ca V 1.2 I-II loop or truncated exons. The immobilized GST or GST-fusion proteins were incubated with cell lysates prepared from A7r5 cells. Glutathione-bound proteins were eluted by boiling at 95°C in 2ϫSDS-sample buffer for 5 minutes, and detected by immunoblotting with anti-Gal-1 (Invitrogen; 1:2000 dilutions) or anti-GST (Santa Cruz; 1:5000 dilutions) antibodies.
Statistical Methods
Averaged data were reported as meanϮSEM. Statistical significance was analyzed using a Student unpaired t test or 1-way analysis of 
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Results
Gal-1 Binds Preferentially to Ca V 1.2 I-II Loop Without Exon 9*
To identify proteins that interact with the I-II loop of Ca V 1.2 channels, we performed yeast 2-hybrid assay and after screening 3.5ϫ10 6 independent clones from human aorta cDNA library, we found 7 positive clones that were confirmed to be human Gal-1. The bait contained the Ca V 1.2 I-II loop that includes exon 9 and 10, but without the alternative spliced exon 9*. 8 To clarify the interacting domain of Gal-1 with I-II loop of Ca V 1.2 channel, we cloned exon 9, exon 9*, exon 10, exons 9ϩ10, and exons 9ϩ9*ϩ10 into pGEX4T-1 expression vector. Using these GST fusion proteins as baits in GST pull-down assays, we found that Gal-1 bound strongly to exon 9 and exons 9ϩ10 GST fusion proteins. The interaction between Gal-1 and exon 9ϩ9*ϩ10 was weak, as only a faint band of Gal-1 was detected ( Figure 1B) .
To further investigate the binding site on exon 9, we generated 2 truncated AID-containing constructs to perform GST pulldown assays. We found that Gal-1 can bind to the portion of exon 9 C-terminus to the AID, but not to the N-terminus ( Figure  1C ). To delineate the binding region, we performed deletional experiments in which 3 amino acids were deleted sequentially from the C-terminus of exon 9. Five deletional exon 9 constructs were generated, and we found that amino acids at positions 40 to 54 of exon 9 are important as binding site for Gal-1 ( Figure 1D ).
Gal-1 Colocalizes With Ca V 1.2 in Arterial Smooth Muscle
The inclusion or exclusion of splice variant exon 9* could be found in human and rat arterial tissues ( Figure 2A ). Similarly, although Ca V 1.2 channels are widely expressed in the cardiovascular system, reverse-transcription polymerase chain reaction and detect rat or human Ca V 1.2 I-II loop inclusive of or in the absence of exon 9* in arterial tissues. PCR products were separated in 2% agarose gel, and both rat and human arteries contained an almost equal amount of products with the inclusion (upper band) or exclusion (lower band) of exon 9*. B, RT-PCR products of Gal-1 mRNA were detected in the human arteries but not in the human heart. Similarly, Gal-1 protein as detected by Western blot analysis was observed in the rat arteries but not the heart tissues. C, Immunofluorescence staining to determine colocalization of ␣-SM actin, Ca V 1.2 channels, and Gal-1 in smooth muscles was carried out using anti-␣-SM actin (left top, 1:100 dilutions), anti-Ca V 1.2 ␣ 1C antibody (left bottom, 1:100 dilutions), and anti-Gal-1 antibody (middle, 1:100 dilutions) in rat mesenteric artery. The right panel shows the merged image.
(RT-PCR) and Western blot analysis showed that Gal-1 was expressed only in the vascular smooth muscle tissue, but not in the heart tissue ( Figure 2B ). We have also investigated the presence of Gal-1 with Ca V 1.2 channels in rat MA by immunofluorescence staining and found strong colocalization of Gal-1 and Ca V 1.2 channels in the arterial wall. Moreover, Gal-1 and ␣-SM actin were colocalized in rat MA, indicating that Gal-1 is selectively expressed in the smooth muscle layer of arteries ( Figure 2C ).
Gal-1 Selectively Regulates the Function of Ca V 1.2 Channel Splice Variants
To date, there are 3 reported dominant splice combinations found in blood vessels, and these variants differ in the utilization of alternative splice sites at the N-terminus, I-II loop, and domain IV S3-S4 regions 9,10,12 ( Figure 3A) . In order to determine the functional interactions between Gal-1 and Ca V 1.2 calcium channels, we performed electrophysiological recordings of the channels heterologously expressed in HEK 293 cells. The Ca V 1.2 77WT channel, which is one of the major isoforms in blood vessel, 8, 10 was cotransfected with Gal-1 into HEK 293 cells. Various electrophysiological properties were evaluated, and we found that Gal-1 caused an Ϸ30% decrease in I Ca,L fluxing through Ca V 1.2 77WT channels. The inhibition by Gal-1 was also observed when Ba 2ϩ was used as the charge carrier ( Figure 3B ), which indicated that the inhibition by Gal-1 was calcium independent. However, channel electrophysiological properties such as the steady state activation and inactivation potentials, and the rate of recovery from inactivation remained similar (Online Figure IIA  and Online Tables II and III) .
To further determine the functional interactions between Gal-1 and Ca V 1.2 channels, we tested the other 2 smooth muscle isoforms: Ca V 1.2 SM and Ca V 1.2 b . 8, 9 There were no significant differences in I Ca,L when HEK 293 cells were cotransfected using Ca V 1.2 SM ( Figure 3C ) or Ca V 1.2 b ( Figure 3D ) channels with Gal-1. The steady state activation and inactivation potentials and the rate of recovery from inactivation were also not obviously changed (Online Figure IIB and IIC and Online  Tables II and III) . However, the major difference observed among the 3 Ca V 1.2 splice variants to explain the selective inhibition by Gal-1 is the lack of exon 9* in the Ca V 1.2 77WT channels. To further validate this observation, we examined the effect of Gal-1 on another Ca V 1.2 splice variant that does not contain exon 9*: Ca V 1.2 CM . This is a predominant cardiac isoform, 9 and we found that Gal-1 significantly decreased the current density ( Figure 3E ). For Ca V 1.2 CM , Gal-1 also rightshifted the steady state inactivation while not affecting the steady state activation and rate of recovery from inactivation (Online Figure IID and Online Tables II and III) .
Gal-1 Decreased the Functional Surface Expression of Ca V 1.2 ⌬9* Channels
To determine the mechanism by which Gal-1 decreases Ca V 1.2 ⌬9* current density, we characterized the ON-gating currents (Q ON ) reflecting the capacitative voltage-sensor movements on depolarization during channel gating by depolarizing cells to positive potentials at which no ionic inward and outward currents were observed when holding at reversal potential, V rev . 19 It is found that coexpression of Gal-1 could reduce Q ON by Ϸ45% in Ca V 1.2 77WT channels, suggesting a lower-level functional expression of the channels on the membrane ( Figure  4B ). Furthermore, the expression of surface Ca V 1.2 77WT channel protein was decreased about 50% when cotransfected with Gal-1 (Online Figure III) . However, there was no significant difference in Q ON in the other 2 smooth muscle Ca V 1.2 channels that contained exon 9* ( Figure 4C and 4D) . Significantly, Ca V 1.2 CM channels that lack exon 9* have also decreased Q ON by Ϸ45% when coexpressed with Gal-1 ( Figure 4E ). Interestingly, when we cotransfected different amounts of Gal-1 with constant amounts of ␤2a and Ca V 1.2 77WT subunits, we showed that Gal-1 dose-dependently inhibits Ca V 1.2 calcium currents (Online Figure IV) . Taken together, these findings strongly suggest that binding of Gal-1 to the I-II loop of Ca V 1.2 channels occurred in the absence of exon 9*. The inhibition of Ca V 1.2 ⌬9* current density is possibly mediated by downregulation of surface expression of the channels via competition between Gal-1 and ␤2a for binding to the I-II loop of Ca V 1.2 or the masking of the endoplasmic reticulum (ER) export signal by Gal-1.
siRNA Mediated Knock-Down of Gal-1 Increases Calcium Channel Currents of VSMCs
To strengthen the hypothesis that Gal-1 reduces Ca V 1.2 currents, we performed the reverse experiment and decreased Gal-1 expression by transfecting siRNA into rat aortic smooth muscle cell (SMC) line A7r5 or isolated rat aortic SMCs. After transfection of Gal-1 siRNAs into A7r5 cells and primary cultured VSMC cells, endogenous Gal-1 protein level was substantially decreased, while nontargeting (NT) siRNA had no effect on Gal-1 expression ( Figure 5A and Online Figure VIA) . Notably, I Ba,L was increased by about 75% in A7r5 cells ( Figure 5B ) and 35% in isolated VSMCs ( Figure 5C ) after Gal-1 siRNA treatment compared with NT siRNA, respectively. However, the steady state inactivation (Online Figure VIB) and rate of recovery from inactivation (Online Figure VIC) in A7r5 cells were not altered by Gal-1 siRNA treatment (Online Table IV) , which is consistent with the data obtained from experiments done in HEK 293 cells. These results indicate that knock-down of Gal-1 in VSMCs could up-regulate calcium currents.
As it has been reported that arterial SMCs also expressed Ca V 1.3 channels, 20 we therefore used 2 concentrations of nifedipine to apply on A7r5 cells to assess the levels of expression of Ca V 1.2 and Ca V 1.3 currents on the basis of their different sensitivities to dihydropyridine (DHP). 21 Here, we found that nifedipine inhibited the calcium currents similarly in 1 mol/L or 10 mol/L of nifedipine (Online Figure VIIA) . Moreover, the increase in I Ba after knock-down of Gal-1 expression by siRNA could be completely blocked by 1 mol/L nifedipine (Online Figure VIIB) . These data indicate that the major calcium currents of VSMCs and the increase in I Ba after Gal-1 knock-down are due to Ca 2ϩ flux through the Ca V 1.2 and not the Ca V 1.3 channels.
Gal-1 Regulates Arterial Constriction
Calcium influx through Ca V 1.2 channels is important for vascular constriction; therefore, we next examined whether Gal-1 could affect vascular constriction. Reversible permeabilization (RP) procedure was used to knock down the expression of Gal-1 in rat MAs in organ bath culture. After 3 days of RP with Gal-1 siRNA, the Gal-1 expression was significantly decreased in rat mesenteric arterial ( Figure 6A ). Vascular constrictions were measured at different days after RP using the Living System. 10, 22 At day 3 after RP, the arteries subjected to Gal-1 siRNA treatment showed larger arterial wall constrictions in stepwise increases of external potassium ions ([K ϩ ] o ) as compared to NT siRNA ( Figure 6B and 6C), but there is no difference in the [K ϩ ] o EC 50 between the Gal-1 siRNA treated and NT siRNA treated arteries (Online Table  V) . However, at days 1 and 2, Gal-1 siRNA had no significant effect on mesentery arterial wall constriction (Online Figure  VIII) . In summary, the absent of Gal-1 up-regulates Ca V 1.2 channel activity, resulting in vasoconstriction of the MAs.
Discussion
The Ca V 1.2 channels are the primary conduits for Ca 2ϩ influx that trigger excitation-contraction coupling in small resistance arteries. Therefore, it is a logical target for homeostatic regulation of Ca 2ϩ influx into a cell via multiple mechanisms, including posttranscriptional and posttranslational modifications or modulations by drugs or cytoplasmic interacting proteins. 23, 24 In this study, we found that (1) Gal-1 could bind to Ca V 1.2 I-II The Ca V 1.2 channels, like other membrane channels and receptors, is a hetero-oligomeric complex that is also associated with signaling molecules, enzymes, or anchoring proteins. To date, several small proteins such as Ca V ␤ subunit, 7 calmodulin, 25, 26 CaMKII (calcium/calmodulin-dependent kinase II), 27 and STIM1 (stromal interacting molecule 1) 28, 29 have been found to bind to the ␣ 1C I-II loop or C-terminus to regulate Ca V 1.2 channel functions. Adding to this list is Gal-1, and interestingly Gal-1 has also been shown to interact with other cell membrane channels or receptors to modulate their functions. Binding of Gal-1 to the renal epithelial Ca 2ϩ channels TRPV5 results in their accumulation on the plasma membrane, 30 while the binding of Gal-1 to CD43 or CD45 on dendritic cells triggers cell activation and migration. 31 Our data showed that Gal-1 inhibits Ca V 1.2 currents via reducing the functional surface expression of the channels without affecting their electrophysiological properties. A possible mechanism is the competition of Gal-1 with Ca V ␤ subunit for binding to exon 9, the segment of the I-II loop where the AID resides. In the absence of Ca V ␤ subunit binding to the AID, the Ca V 1.2 channels could be subject to proteasomal degradation via the endoplasmic reticulum-associated protein degradation (ERAD) complex. 32 Di-acidic motifs (DxD, DxE, ExD, and ExE, where x is any amino acid) have been found to act as ER export signals in many membrane proteins. [33] [34] [35] Recently, an ␣ 1C export signal was reported to be located at the C-terminus of exon 9 (DIDPENEDEGMDEE), which is rich in di-acidic motifs, next to the AID domain. The report also showed that the Ca V ␤ subunit may interact with this ER export signal to affect the trafficking of the ␣ 1C subunits from the ER to surface membrane, as mutations generated in this region decreased functional Ca V 1.2 surface expression and hence decreased the maximal gating currents. 36 Here, we have demonstrated that the Gal-1 also binds to this ER export signal, which therefore provides another mechanistic understanding of how Gal-1 may mask the ER export signal to affect Ca V 1.2 ⌬9* channel surface expression and current density.
Gal-1 was found to be involved in the attachment, spreading, migration, and proliferation of VSMC. 16, 37, 38 Notably, Gal-1 could inhibit VSMC spreading and migration via interactions with extracellular matrix proteins and ␣1␤1 integrin 37 ; moreover, it has also been shown that Gal-1 inhibits VSMC adhesion by activating ␤1 integrin and phosphorylating focal adhesion kinase. 38 Importantly, Ca 2ϩ influx through LTCC also mediates VSMC attachment, spreading, and migration. 39, 40 As we have demonstrated that the I Ca,L of VSMCs was significantly increased after knocking down the expression of Gal-1, it is highly possible that effects of Gal-1 expression on SMC attachment, spreading, and migration might be attributed to the downregulation of Ca V 1.2 channel surface expression.
Exon 9* is an alternatively splice exon that is 25 amino acids in size and is situated between exons 9 and 10 that code for the ␣ 1C I-II loop. 8 Subpopulation of Ca V 1.2 channels containing exon 9*are likely to maintain vasotone due to their unique localization and electrophysiological properties. 8, 10 Here, we report a novel splice-variant specific regulation of Ca V 1.2 channels by Gal-1: that Gal-1 can inhibit the function of Ca V 1.2 ⌬9* channels, but this inhibition by Gal-1 is abolished by the inclusion of exon 9*. Interestingly, in silico computer secondary structure prediction of Ca V 1.2 I-II loop indicates that in the presence of exon 9* the likelihood of forming an ␣-helix in the ER export signal region is significantly increased (Online Figure V) . Whether the affinity of binding of Gal-1 to the ER export signal depends on the secondary structure of this signal will require future work. An alternative explanation could be that the Gal-1 ER export signal, which contains many negatively charged amino residues, may interact with the positively charged amino acids found in the neighboring exon 9*, and hence this interaction abrogates Gal-1 binding and modulation. Such an interaction between exon 9* and the ER export signal may also affect surface expression, and we observed that the current density of exon 9*-containing Ca V 1.2 channels (Ca V 1.2 b ) are significantly lower than those that do not contain exon 9* (Ca V 1.2 77WT ) ( Figure 3B and 3D) . Taken together, these results suggest that the inclusion of exon 9* will prevent the interaction between Gal-1 and Ca V 1.2 9* channels or that the ER export signal is masked by exon 9* and still allowing the subpopulation of Ca V 1.2 9* channels to continue in its role to maintain vasotone. 8, 10 However, exon 9* was found to be absent in VSMC in the pathological disease, such as atherosclerosis. 41 Therefore, Gal-1 could be an important modulator of pathological electric remodeling in blood vessels, and it would be of interest to examine the level of expression Gal-1 in arteries from atherosclerotic or hypertensive patients or in any rodent models of hypertension to ascertain whether Gal-1 expression is a cause or a compensatory mechanism in the pathogenesis of hypertension.
Vascular hypertension has been shown to be tightly associated with the enhanced activity of the vascular Ca V 1.2 calcium channels. Significantly, the VSMCs of hypertensive rats have increased surface expression of Ca V 1.2 calcium channels that contributed to elevated Ca 2ϩ influx and the development of abnormal arterial tone. 3, 42 Whole-cell electrophysiological recordings of VSMC isolated from SHR rats showed elevated currents. 43, 44 Furthermore, single-channel recordings revealed an increased number of Ca V 1.2 calcium channel openings, while single-channel conductance or opentime distribution remained unchanged. 45 Our data showed that overexpression of Gal-1 can decrease the functional surface expression of Ca V 1.2. Conversely, knock-down of Gal-1 protein level by siRNA increased I Ca,L in rat A7r5 cells and isolated VSMCs. In rat MAs, the functional outcome of knock-down of Gal-1 was larger maximal constriction induced by extracellular K ϩ . These observations suggest that the absence of Gal-1 in resistance arteries contributes to higher blood pressure, and indeed Gal-1 -/-null mice showed a greater response in the increase of right ventricular and pulmonary arterial blood pressure caused by acute hypoxia compared with wild-type mice. 18 Taken together, our data highlight that Gal-1 modulates the Ca V 1.2 currents in a splice variant specific manner, and its dynamic expression influences arterial constrictions. Therefore, it is reasonable to believe that Gal-1 may play some roles in hypertension via regulating arterial wall constriction, and due to its selective expression in the blood vessels, Gal-1 may be a promising target in the management of vascular hypertension.
function of VSMCs via Ca V 1.2 channels. Down-regulation of Gal-1 increases arterial constriction, suggesting that Gal-1's regulation in blood vessels may play a role in hypertension.
The Ca V 1.2 calcium channels open on sensing membrane depolarization to form conduits for large and rapid Ca 2ϩ influx that leads to muscle contraction. The electrophysiological and pharmacological properties of the channel can be modified via alternative splicing, a posttranscriptional mechanism that could generate subtle modifications in channel structure. The channel function can also be modulated through binding with cytoplasmic proteins. We show that Gal-1 reduces the surface expression of Ca V 1.2 channels that do not contain alternative exon 9*, via the possible masking of the ER export signal found on the C-terminal portion of exon 9. The presence of exon 9* was predicted by in silico protein structure software to induce the formation of an ␣-helical structure in the ER export signal to either prevent the binding of Gal-1 or interact with exon 9* to mask the ER export signal. Importantly, down-regulation of Gal-1 increases Ca V 1.2 channel expression and contractility of mesenteric arteries. As Gal-1 is expressed in smooth and not cardiac muscles, it may potentially be a therapeutic target to the pathogenesis of hypertension.
